BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2138919)

  • 21. Role of polyamines in the growth of hormone-responsive and -resistant human breast cancer cells in nude mice.
    Manni A; Badger B; Martel J; Demers L
    Cancer Lett; 1992 Sep; 66(1):1-9. PubMed ID: 1451091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer.
    Taras TL; Wurz GT; DeGregorio MW
    J Steroid Biochem Mol Biol; 2001 Jun; 77(4-5):271-9. PubMed ID: 11457665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha.
    Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA
    Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of nitric oxide production by droloxifene and toremifene in human breast cancer cells.
    Martin JH; Symonds A; Chohan S
    Oncol Rep; 2003; 10(4):979-84. PubMed ID: 12792756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additive and synergistic antitumor effects with toremifene and interferons.
    Kangas L; Cantell K; Schellekens H
    J Steroid Biochem; 1990 Jun; 36(3):259-62. PubMed ID: 2142249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toremifene in postmenopausal breast cancer. Efficacy, safety and cost.
    Mäenpää JU; Ala-Fossi SL
    Drugs Aging; 1997 Oct; 11(4):261-70. PubMed ID: 9342556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
    Lindner DJ; Borden EC
    J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of a novel antiestrogen (Analog II) on human breast cancer cells.
    Jain PT; Rajah TT; Pento JT
    Anticancer Drugs; 1997 Nov; 8(10):964-73. PubMed ID: 9436640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of transforming growth factor beta by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells.
    Knabbe C; Zugmaier G; Schmahl M; Dietel M; Lippman ME; Dickson RB
    Am J Clin Oncol; 1991; 14 Suppl 2():S15-20. PubMed ID: 1835818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G; Katzenellenbogen BS
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen and oncogene mediated growth regulation of human breast cancer cells.
    Kasid A; Lippman ME
    J Steroid Biochem; 1987; 27(1-3):465-70. PubMed ID: 3501040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antitumor activity of miproxifene phosphate (TAT-59) against human mammary carcinoma].
    Toko T; Saito H; Fujioka A; Nukatuka M; Sato K; Hashimoto A; Shibata J; Yamada Y
    Gan To Kagaku Ryoho; 1998 May; 25(6):829-38. PubMed ID: 9617321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of a novel cyclopropyl antiestrogen (compound 7a) on human breast cancer cells in culture.
    Jain PT; Pento JT; Magarian RA
    Breast Cancer Res Treat; 1993; 25(3):225-33. PubMed ID: 8369524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor mechanism of action of a cyclopropyl antiestrogen (compound 7b) on human breast cancer cells in culture.
    Jain PT; Pento JT; Magarian RA
    Cancer Chemother Pharmacol; 1996; 38(3):238-44. PubMed ID: 8646798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro.
    Wärri AM; Huovinen RL; Laine AM; Martikainen PM; Härkönen PL
    J Natl Cancer Inst; 1993 Sep; 85(17):1412-8. PubMed ID: 8350365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE; Larsen SS; Briand P
    Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M; Bicknell R; Harris AL
    Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.